NCT02366494View on ClinicalTrials.gov

Micro RNAs to Predict Response to Androgen Deprivation Therapy

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

April 29, 2015

Primary Completion Date

May 11, 2021

Study Completion Date

May 11, 2021

Conditions
Prostate Cancer
Interventions
DRUG

Bicalutamide

ANDROGEN BLOCKADE

DRUG

Leuprolide

ANDROGEN BLOCKADE

DRUG

Goserelin

ANDROGEN BLOCKADE

DRUG

Triptorelin

ANDROGEN BLOCKADE

DRUG

Docetaxel

Chemo hormonal therapy

DRUG

Abiraterone

Chemo hormonal therapy

DRUG

Apalutamide

Nonsteroidal antiandrogen medication

DRUG

Enzalutamide

Nonsteroidal antiandrogen medication

Trial Locations (1)

53226

Froedtert Hospital, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT02366494 - Micro RNAs to Predict Response to Androgen Deprivation Therapy | Biotech Hunter | Biotech Hunter